Septerna SEPN
NASDAQ SEPN
$51.11 +0.37 (+0.73%)
As of: Nov 10, 2026 · 2:50 PM EST

Septerna (SEPN) EPS (Diluted) (2023 - 2026)

Updated

Septerna (SEPN) reported EPS (Diluted) of -$0.29 for Q2 2026, compared with -$0.56 a year earlier.

Analysis

Septerna (SEPN) EPS (Diluted) (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Septerna's EPS (Diluted) came in at -$0.54; for FY2025, it was -$1.10.

  • By year, EPS (Diluted) came in at -$7.26 in FY2024 and $1.92 in FY2023.
  • Five-year quarterly EPS (Diluted) spans a low of -$8.40 in Q3 2024 and a high of $16.03 in Q4 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$0.19 (Q1 2026), -$0.24 (Q4 2025) and $0.18 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.22
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.09
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 2.38
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.04
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.67
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.60
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 7.08
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.94
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.56
10 Septerna 2.27 Bn 687.56 Mn - -0.29
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.29
Mar 31, 2026 -0.19
Dec 31, 2025 -0.24
Sep 30, 2025 0.18
Jun 30, 2025 -0.56
Mar 31, 2025 -0.49
Dec 31, 2024 -2.09
Sep 30, 2024 -8.40
Jun 30, 2024 -7.06
Mar 31, 2024 -6.32
Dec 31, 2023 16.03
Sep 30, 2023 -5.45
API Access

Septerna EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=SEPN&period=max&api_key=YOUR_API_KEY